Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Re Offer Discussions

19 Sep 2007 07:02

ABCAM Plc19 September 2007 For immediate release 19 September 2007 ABCAM PLC ("Abcam" or "the Company") Offer Talks Terminated Cambridge UK: On 27 July 2007 the Company announced that it was in preliminarydiscussions with a small number of potential offerors regarding a possible offerfor the Company. The Board of Abcam would like to notify the market that thesediscussions have now terminated. Current trading remains strong and the Board is confident of the outlook for2008. Abcam will announce its results for the year ended 30 June 2007 on 1 October2007. For further information please contact: Abcam + 44 (0) 1223 696000 Jonathan Milner, Chief Executive OfficerEddie Powell, Chief Financial Officerwww.abcam.com Numis Securities Ltd + 44 (0) 20 7260 1000Michael MeadeJames Black Piper Jaffray Ltd +44 (0) 20 3142 8700Neil MackisonJames Steel Buchanan Communications + 44 (0) 20 7466 5000Mark Court / Mary-Jane Johnson Notes for editors: About Abcam plc Abcam is a producer and distributor of research-grade antibodies headquarteredin Cambridge, UK, with a US office located in Cambridge, Massachusetts, and aJapan office in Tokyo. Abcam was admitted to AIM in November 2005 and tradesunder the ticker symbol ABC. The Company produces and distributes its own andthird party produced antibodies to academic and commercial users throughout theworld with product information provided and ordering available through theCompany's website, www.abcam.com. The antibodies are sold under the Abcam brandname. The Company's vision is to build the largest online antibody resource inthe world while also ensuring that the antibodies are of high quality andcommercially viable. Abcam now has an online catalogue of approximately 35,000products, most of which are antibodies, from over 200 suppliers supported byup-to-date and detailed technical data sheets, which are created by the Company.The Company currently employs 130 staff in its three operating companies. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Dec 20162:56 pmRNSDirector/PDMR Shareholding
8th Dec 20165:09 pmRNSDirector/PDMR Shareholding
5th Dec 20162:45 pmRNSDirector/PDMR Shareholding
1st Dec 20164:01 pmRNSTotal Voting Rights
10th Nov 20162:00 pmRNSApplication for admission to trading
10th Nov 20167:00 amRNSAxioMx technology milestones accelerated
7th Nov 201611:21 amRNSDirector/PDMR Shareholding
7th Nov 20169:30 amRNSDirector/PDMR Shareholding
2nd Nov 20164:22 pmRNSResult of AGM
2nd Nov 20167:00 amRNSAGM Statement
1st Nov 20163:02 pmRNSTotal Voting Rights
27th Oct 20167:00 amRNSDirector/PDMR Shareholding
24th Oct 20167:00 amRNSNew facility at Cambridge Biomedical Campus
3rd Oct 20161:07 pmRNSTotal Voting Rights
3rd Oct 20167:00 amRNSDirector/PDMR Shareholding
28th Sep 20168:43 amRNSDirector/PDMR Shareholding
26th Sep 20167:19 amRNSAnnual Financial Report
21st Sep 20167:00 amRNSHolding(s) in Company
21st Sep 20167:00 amRNSDirector/PDMR Shareholding
15th Sep 20162:25 pmRNSDirector/PDMR Shareholding
12th Sep 20167:00 amRNSPreliminary Results
2nd Sep 20167:00 amRNSApplication for admission to trading
24th Aug 20167:00 amRNSNotice of Results
23rd Aug 20163:01 pmRNSBlock listing Interim Review
3rd Aug 20167:00 amRNSDirectorate Change
1st Aug 20161:11 pmRNSTotal Voting Rights
25th Jul 20167:00 amRNSPre-Close Period Update
1st Jul 20162:12 pmRNSTotal Voting Rights
20th Jun 20167:00 amRNSAbcam to appoint Gavin Wood as CFO
1st Jun 20164:38 pmRNSTotal Voting Rights
3rd May 20162:03 pmRNSTotal Voting Rights
19th Apr 20162:35 pmRNSDirector/PDMR Shareholding
1st Apr 20161:50 pmRNSTotal Voting Rights
24th Mar 20162:29 pmRNSDirector/PDMR Shareholding
24th Mar 20167:00 amRNSPosting of Half Yearly Report
22nd Mar 20169:33 amRNSDirector/PDMR Shareholding
7th Mar 20167:00 amRNSDirectorate Change
7th Mar 20167:00 amRNSHalf Yearly Report
10th Feb 201610:59 amRNSNotice of Results
8th Feb 20163:58 pmRNSBlocklisting Interim Review
1st Feb 20162:06 pmRNSTotal Voting Rights
29th Jan 20163:09 pmRNSHolding(s) in Company
25th Jan 20167:00 amRNSHalf Year Trading Update
4th Jan 20163:02 pmRNSTotal Voting Rights
7th Dec 20153:57 pmRNSDirector/PDMR Shareholding
7th Dec 20151:59 pmRNSDirector/PDMR Shareholding
1st Dec 20154:30 pmRNSTotal Voting Rights
12th Nov 20153:22 pmRNSApplication for admission to trading - update
12th Nov 20152:56 pmRNSDirector/PDMR Shareholding
11th Nov 20154:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.